JW (Cayman) Therapeutics Co. Ltd (JWCTF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 318.79 Million CNY | 14.21% |
| 2022 | 279.12 Million CNY | 89.84% |
| 2021 | 147.03 Million CNY | 18.97% |
| 2020 | 123.59 Million CNY | 58.89% |
| 2019 | 77.78 Million CNY | 32.53% |
| 2018 | 58.69 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 333.6 Million CNY | 4.64% |
| 2024 Q2 | 333.6 Million CNY | 0.0% |
| 2023 FY | 318.79 Million CNY | 14.21% |
| 2023 Q3 | 302.79 Million CNY | -22.49% |
| 2023 Q2 | 390.63 Million CNY | 3.7% |
| 2023 Q1 | 376.7 Million CNY | 34.96% |
| 2023 Q4 | 318.79 Million CNY | 5.29% |
| 2022 Q4 | 279.12 Million CNY | 3.95% |
| 2022 Q2 | 150.02 Million CNY | 10.16% |
| 2022 Q1 | 136.18 Million CNY | -7.38% |
| 2022 FY | 279.12 Million CNY | 89.84% |
| 2022 Q3 | 268.52 Million CNY | 78.99% |
| 2021 Q1 | 111.96 Million CNY | -9.41% |
| 2021 FY | 147.03 Million CNY | 18.97% |
| 2021 Q4 | 147.03 Million CNY | 11.52% |
| 2021 Q3 | 131.84 Million CNY | 4.59% |
| 2021 Q2 | 126.06 Million CNY | 12.6% |
| 2020 FY | 123.59 Million CNY | 58.89% |
| 2020 Q1 | 2.74 Billion CNY | 3434.92% |
| 2020 Q3 | 112.71 Million CNY | -7.81% |
| 2020 Q2 | 122.25 Million CNY | -95.55% |
| 2020 Q4 | 123.59 Million CNY | 9.65% |
| 2019 Q3 | 1.48 Billion CNY | 0.0% |
| 2019 FY | 77.78 Million CNY | 32.53% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q4 | 77.78 Million CNY | -94.77% |
| 2018 FY | 58.69 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Agentix Corp. | 50 Thousand USD | -637490.0% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -5329.912% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -124628.082% |
| Biomind Labs Inc. | 735.54 Thousand USD | -43241.509% |
| ContraFect Corporation | 2.88 Million USD | -10965.429% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -23627.21% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -25852.875% |
| CSL Limited | 12.18 Billion USD | 97.383% |
| CytoDyn Inc. | 30.07 Million USD | -959.965% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -635.008% |
| GB Sciences, Inc. | 1.75 Million USD | -18020.487% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -88525.559% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -50496.197% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -599.726% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -33518.554% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -42057.275% |
| Skye Bioscience, Inc. | 4.61 Million USD | -6807.403% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -970.963% |
| SQZ Biotechnologies Company | 27.47 Million USD | -1060.478% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -35797.751% |
| Zenith Capital Corp. | 10.22 Thousand USD | -3117699.511% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -673.718% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -13605.983% |
| Mesoblast Limited | 118.7 Million USD | -168.571% |
| Marizyme, Inc. | 18.71 Million USD | -1603.193% |
| Genus plc | 233.1 Million USD | -36.763% |
| Pharming Group N.V. | 171.54 Million USD | -85.838% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -42406.0% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -21941.818% |
| IMV Inc. | 28.88 Million USD | -1003.712% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -5534.06% |
| MultiCell Technologies, Inc. | 202.58 USD | -157367359.769% |
| ONE Bio Corp. | 19.71 Million USD | -1517.016% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -454.532% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -863.098% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -10434.53% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -2352.836% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -225168.164% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -1239431.086% |
| Alpha Cognition Inc. | 1.22 Million USD | -26022.772% |
| Enzolytics Inc. | 996.33 Thousand USD | -31896.672% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 20 Million USD | -1493.975% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -4407.332% |
| Genscript Biotech Corporation | 417.73 Million USD | 23.686% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -7634.069% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -79232.038% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -13195.734% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -138935.113% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -214354.371% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -10778.935% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -235195.637% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -21227.632% |
| Q BioMed Inc. | 4.1 Million USD | -7656.605% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -1468.256% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -371.292% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 4.71 Million USD | -6666.436% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -14016.086% |
| HST Global, Inc. | 98.31 Thousand USD | -324145.568% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -128074.252% |
| Halberd Corporation | 150 Thousand USD | -212430.0% |
| Resverlogix Corp. | 6.49 Million USD | -4811.339% |
| Cell Source, Inc. | 9.25 Million USD | -3344.878% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -11669.286% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -158808.063% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 2.19 Million USD | -14391.472% |
| Kadimastem Ltd | 891.22 Thousand USD | -35670.388% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -151005.581% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -127325.234% |
| LadRx Corporation | 33.6 Thousand USD | -948525.245% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -42057.275% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | 228.37 Thousand USD | -139491.553% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -6297.652% |
| Mobile Lads Corp. | 484.28 Thousand USD | -65728.109% |
| International Stem Cell Corporation | 4.17 Million USD | -7530.326% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | 1.92 Million USD | -16460.779% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -90506.144% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -3976.683% |
| SYBLEU INC | 477.5 Thousand USD | -66663.351% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -260140.816% |
| Rebus Holdings, Inc. | 310 Thousand USD | -102737.097% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -6632.334% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -510683.01% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -14517.589% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -3733.514% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -3613.395% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -20394.973% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -118853.358% |
| Neutra Corp. | 54.15 Thousand USD | -588560.536% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -17320.492% |
| PureTech Health plc | 25.51 Million USD | -1149.588% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -25940.535% |
| IXICO plc | 472.02 Thousand USD | -67438.023% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -1956.609% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -412.014% |
| CSL Limited | 12.18 Billion USD | 97.383% |
| Cellectis S.A. | 92.77 Million USD | -243.616% |